1. Home
  2. EOLS vs TRAK Comparison

EOLS vs TRAK Comparison

Compare EOLS & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • TRAK
  • Stock Information
  • Founded
  • EOLS 2012
  • TRAK 1990
  • Country
  • EOLS United States
  • TRAK United States
  • Employees
  • EOLS N/A
  • TRAK N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • TRAK EDP Services
  • Sector
  • EOLS Health Care
  • TRAK Technology
  • Exchange
  • EOLS Nasdaq
  • TRAK Nasdaq
  • Market Cap
  • EOLS 412.0M
  • TRAK 374.5M
  • IPO Year
  • EOLS 2018
  • TRAK 1998
  • Fundamental
  • Price
  • EOLS $6.73
  • TRAK $16.43
  • Analyst Decision
  • EOLS Strong Buy
  • TRAK
  • Analyst Count
  • EOLS 5
  • TRAK 0
  • Target Price
  • EOLS $21.25
  • TRAK N/A
  • AVG Volume (30 Days)
  • EOLS 2.3M
  • TRAK 52.3K
  • Earning Date
  • EOLS 08-05-2025
  • TRAK 09-29-2025
  • Dividend Yield
  • EOLS N/A
  • TRAK 0.44%
  • EPS Growth
  • EOLS N/A
  • TRAK 21.41
  • EPS
  • EOLS N/A
  • TRAK 0.34
  • Revenue
  • EOLS $277,941,000.00
  • TRAK $22,028,373.00
  • Revenue This Year
  • EOLS $33.42
  • TRAK $15.18
  • Revenue Next Year
  • EOLS $33.18
  • TRAK $10.00
  • P/E Ratio
  • EOLS N/A
  • TRAK $48.34
  • Revenue Growth
  • EOLS 17.15
  • TRAK 9.73
  • 52 Week Low
  • EOLS $5.71
  • TRAK $15.12
  • 52 Week High
  • EOLS $17.82
  • TRAK $25.01
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 33.84
  • TRAK 36.14
  • Support Level
  • EOLS $6.21
  • TRAK $16.28
  • Resistance Level
  • EOLS $6.74
  • TRAK $17.38
  • Average True Range (ATR)
  • EOLS 0.45
  • TRAK 0.76
  • MACD
  • EOLS -0.16
  • TRAK 0.09
  • Stochastic Oscillator
  • EOLS 27.49
  • TRAK 38.99

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.

Share on Social Networks: